Key Findings:  This review discusses how synthetic derivatives of THCV interact with CB1 and CB2 receptors and suggests it acts as a neutral antagonist and partial agonist.
Type of Study:  Meta-analysis
Study Result:  Inconclusive
Study Location(s):  Italy, United Kingdom
Year of Pub:  2020
Cannabinoids Studied:  Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source:  Not Applicable